Clinical Trials Browser

Phase 2 × Hormone Refractory Prostate Cancer × Docetaxel × Clear all

NCT00313482 2012-05-11

PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

Phase 2 Terminated

Hormone Refractory Prostate Cancer

NCT00525408 2012-03-12

HRPC

Phase 2 Terminated

Hormone Refractory Prostate Cancer

NCT00795171 2010-08-18

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Phase 2 Unknown

Hormone Refractory Prostate Cancer